Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Catherine Bonnefont-Rebeix"'
Autor:
Mehrdad Khoshnevis, Richard Brown, Sara Belluco, Ilyes Zahi, Luca Maciocco, Catherine Bonnefont-Rebeix, Elodie Pillet-Michelland, Jonathan Tranel, Thierry Roger, Christophe Nennig, Patrick Oudoire, Lionel Marcon, Olivier Tillement, Cédric Louis, Hélène Gehan, Manuel Bardiès, Maurizio Mariani, Valeria Muzio, Jean-Philippe Meunier, Charlotte Duchemin, Nathalie Michel, Estelle N’Tsiba, Ferid Haddad, Thierry Buronfosse, Claude Carozzo, Frédérique Ponce
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Glioblastoma is considered the most common malignant primary tumor of central nervous system. In spite of the current standard and multimodal treatment, the prognosis of glioblastoma is poor. For this reason, new therapeutic approaches need to be dev
Externí odkaz:
https://doaj.org/article/8aada16306dc42f0904f1ec20a17adaf
Autor:
Mehrdad Khoshnevis, Claude Carozzo, Richard Brown, Manuel Bardiès, Catherine Bonnefont-Rebeix, Sara Belluco, Christophe Nennig, Lionel Marcon, Olivier Tillement, Hélène Gehan, Cédric Louis, Ilyes Zahi, Thierry Buronfosse, Thierry Roger, Frédérique Ponce
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0234772 (2020)
Glioblastoma is the most aggressive primary brain tumor leading to death in most of patients. It comprises almost 50-55% of all gliomas with an incidence rate of 2-3 per 100,000. Despite its rarity, overall mortality of glioblastoma is comparable to
Externí odkaz:
https://doaj.org/article/ca007830bfb549eba8364395c7172873
Autor:
Hugo Marchal-Chaud, Romain Rieger, Van Than Mai, Edwin-Joffrey Courtial, Mélanie Ottenio, Catherine Bonnefont-Rebeix, Karine Bruyère, Caroline Boulocher
Publikováno v:
Biomaterials Advances. 149:213401
Autor:
Mehrdad, Khoshnevis, Richard, Brown, Sara, Belluco, Ilyes, Zahi, Luca, Maciocco, Catherine, Bonnefont-Rebeix, Elodie, Pillet-Michelland, Jonathan, Tranel, Thierry, Roger, Christophe, Nennig, Patrick, Oudoire, Lionel, Marcon, Olivier, Tillement, Cédric, Louis, Hélène, Gehan, Manuel, Bardiès, Maurizio, Mariani, Valeria, Muzio, Jean-Philippe, Meunier, Charlotte, Duchemin, Nathalie, Michel, Estelle, N'Tsiba, Ferid, Haddad, Thierry, Buronfosse, Claude, Carozzo, Frédérique, Ponce
Publikováno v:
Frontiers in oncology. 12
Glioblastoma is considered the most common malignant primary tumor of central nervous system. In spite of the current standard and multimodal treatment, the prognosis of glioblastoma is poor. For this reason, new therapeutic approaches need to be dev
Autor:
Cédric Louis, Lionel Marcon, Mehrdad Khoshnevis, Catherine Bonnefont-Rebeix, Frédérique Ponce, Thierry Buronfosse, T. Roger, Claude Carozzo, Richard Brown, Manuel Bardiès, Olivier Tillement, Hélène Gehan, Christophe Nennig, Sara Belluco, Ilyes Zahi
Publikováno v:
PLoS ONE
PLoS ONE, 2020, 15 (6), pp.e0234772. ⟨10.1371/journal.pone.0234772⟩
PLoS ONE, Public Library of Science, 2020, 15 (6), pp.e0234772. ⟨10.1371/journal.pone.0234772⟩
PLoS ONE, Vol 15, Iss 6, p e0234772 (2020)
PLoS ONE, 2020, 15 (6), pp.e0234772. ⟨10.1371/journal.pone.0234772⟩
PLoS ONE, Public Library of Science, 2020, 15 (6), pp.e0234772. ⟨10.1371/journal.pone.0234772⟩
PLoS ONE, Vol 15, Iss 6, p e0234772 (2020)
International audience; Glioblastoma is the most aggressive primary brain tumor leading to death in most of patients. It comprises almost 50-55% of all gliomas with an incidence rate of 2-3 per 100,000. Despite its rarity, overall mortality of gliobl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::128548ab9e9048f662cf158be98a0e6c
https://www.hal.inserm.fr/inserm-02907080/document
https://www.hal.inserm.fr/inserm-02907080/document
Autor:
Sara Belluco, Frédérique Ponce, Elodie Pillet-Michelland, T. Roger, Olivia Leveneur, Matthieu Dreyfus, Mehrdad Khoshnevis, Claude Carozzo, Thomas Chuzel, François Berger, Catherine Bonnefont-Rebeix
Publikováno v:
Journal of neuroscience methods. 282
Background Glioblastoma is the most common and deadliest primary brain tumor for humans. Despite many efforts toward the improvement of therapeutic methods, prognosis is poor and the disease remains incurable with a median survival of 12–14.5 month
Autor:
Caroline Leroux, Janine Bernaud, Jean-Jacques Pin, Dominique Rigal, T. Marchal, L. Chabanne, Catherine Bonnefont-Rebeix, Serge Lebecque
Publikováno v:
Veterinary Immunology and Immunopathology
Veterinary Immunology and Immunopathology, Elsevier, 2007, 118 (1-2), pp.134-139. ⟨10.1016/j.vetimm.2007.04.008⟩
Veterinary Immunology and Immunopathology, 2007, 118 (1-2), pp.134-139. ⟨10.1016/j.vetimm.2007.04.008⟩
Veterinary Immunology and Immunopathology, Elsevier, 2007, 118 (1-2), pp.134-139. ⟨10.1016/j.vetimm.2007.04.008⟩
Veterinary Immunology and Immunopathology, 2007, 118 (1-2), pp.134-139. ⟨10.1016/j.vetimm.2007.04.008⟩
International audience; Toll-like receptors (TLRs) are a family of functionally important receptors for recognition of pathogen-associated molecular pattern (PAMP) since they trigger the pro-inflammatory response and upregulation of costimulatory mol
Publikováno v:
Pathologie Biologie. 54:85-93
The comprehension of the immune system and the role of DC in the pathological diseases may contribute to their use in veterinary medicine in the prevention and treatment of many diseases. Currently, most dendritic cell (DC) research occurs in the hum
Autor:
Dominique Rigal, Janine Bernaud, L. Chabanne, Camila Miranda de Carvalho, T. Marchal, Catherine Bonnefont-Rebeix
Publikováno v:
Veterinary Immunology and Immunopathology. 109:167-176
In this study, canine monocyte-derived dendritic cells (cMo-DC) were produced in presence of canine GM-CSF (cGM-CSF) and canine IL-4 (cIL-4), and they were characterized by their dendritic morphology, MLR functionality and phenotype. We noticed that
Publikováno v:
Comparative Clinical Pathology. 13:109-118
Among 276 canine lymphomas referred to the Haematology–Cytology–Immunology laboratory of the Lyon Veterinary School between 1997 and 2003, there were five aggressive large granular lymphocyte (LGL) malignancies. The five dogs were clinically exam